Medical device outsourcing company Vention Medical has acquired ATEK Medical Group, a leader in medical device assembly, packaging and injection moulding.

Dan Croteau, CEO of Vention Medical, said, “Our partnership with the ATEK Medical Group management team will allow Vention to provide an enhanced customer experience. Like Vention, ATEK Medical Group aspires to continually satisfy customers through intense focus on services that improve quality, innovation, and cost.”

The acquisition will incur a variety of combined capabilities and services, including product design and development, innovative component technologies, along with the manufacturing space of 175,000 square feet at its Costa Rica campus.

ATEK recently opened a second facility in Grand Rapids, Michigan, to support customer demands in the US.

Chris Oleksy, President of ATEK Medical, and Tom Houdeshell of ATEK Plastics, said that Vention’s experience and capabilities in design, components and assembly makes Vention “a very appealing partner for us”.

Vention Medical specialises in components and services used in interventional and minimally-invasive products, including medical balloons, advanced extrusions and heat shrink tubing, clean room injection moulding, assembly and packaging services.

Boston Scientific has launched its new balloon dilation catheter, Coyote, to treat patients undergoing peripheral angioplasty procedures below the knee.

The Coyote Balloon Catheter is intended to help physicians when treating patients who have challenging obstructive lesions in the lower extremities.

With an ultra-low profile of 0.0174 inches, it promises to be highly deliverable and offer rapid deflation.

Balloon catheters are often used during peripheral angioplasty and stenting procedures to open blocked arteries.

J. A. Mustapha, Director of Endovascular Intervention at Metro Health Hospital in Wyoming, Michigan, said: “Its performance gives me greater confidence in being able to effectively treat patients with difficult anatomy who suffer from peripheral artery disease.”

The device is the latest in a series of balloon catheter products developed by Boston Scientific.  In June, the company launched its Mustang PTA Balloon Catheter, a 0.035 inch percutaneous transluminal angioplasty (PTA) catheter designed to be used in a range of peripheral angioplasty procedures.

Jeff Mirviss, President of Boston Scientific's Peripheral Interventions Division, said the new product launch “builds on Boston Scientific's global leadership in low-profile peripheral balloon angioplasty”.

Up to 9 million US patients suffer from peripheral artery disease, which is associated with high rates of morbidity.

Boston Scientific has begun marketing the product in the US, Europe and other international markets.